Microbiological Testing/Measurement TRIZ Cases

A porous pad containing luciferase and luciferin enables bioluminescent ATP detection within a sealed wound dressing.

Separating vesicular from cell-free nucleic acid in maternal blood samples to enrich fetal DNA for genetic analysis.

Replacing bacterial culture with molecular RNA detection to reduce time to susceptibility data and limit broad-spectrum antibiotic use.

TAPS method detects cytosine modifications via TET oxidation and borane reduction, preserving sample integrity lost in harsh bisulfite sequencing.

Combined MAL and hsa-miR124 promoter methylation analysis detects high-grade precursor lesions in self-sampled specimens.

Introducing a mutant cyclin F-box gene enables autonomous parthenocarpy and higher sugar levels, eliminating labor-intensive hormone treatments.

An enzymatic cascade converts choline to hydrogen peroxide for spectrophotometric analysis at 650 nm, resolving plasma color interference in biological samples.

Nanowires convert fluorescence light into electrical signals, resolving spatial resolution limits in parallel detection.

Filter paper carriers stabilize dry DNA at room temperature, eliminating cold storage costs and labor-intensive extraction steps.

Targeting rs144012689 eliminates false negatives in HLA-B*15:02 detection, resolving the contradiction between measurement precision and screening throughput.

Selective DNA sequencing quantifies genetic variances to generate pathogen resistance profiles.

Electron spin centers detect magnetic shifts from paramagnetic ions to resolve ionic current sensing errors in label-free sequencing.

Cell-free DNA analysis from peripheral blood replaces invasive bone marrow biopsies to detect myelodysplastic syndrome mutations with high sensitivity.

Biomarker nanoparticles use photolabile groups to enable precise in vivo protease activity measurements.

Introducing the bil7 gene overcomes limited effectiveness of brassinosteroid biosynthesis genes to reliably increase crop productivity.

A partitioned system extends primers and joins barcode molecules using splint sequences to generate barcoded nucleic acid products.

Universal primers and differentially labeled probes enable simultaneous viral load quantification and genotype determination in a single reaction.

Hybridization barcoding maps protein-nucleic acid interactions in tissue, resolving the trade-off between spatial resolution and detection throughput.

A microbiome monitoring method extracts protein sequences to quantify expressed biomass using mass spectrometry.

Trapped charge in nanopore wells enables controlled pore insertion, reducing membrane damage and improving signal reliability.

A gap structure separates hematocrit and glucose electrodes to prevent cross-interference while maintaining a compact flow path volume.

Segmenting bulk populations into isolated compartments concentrates secreted biomolecules, resolving the trade-off between throughput and detection precision.

Folding a single-layer substrate positions electrodes on opposite sides, reducing manufacturing complexity while enhancing measurement precision.

Copper nanoparticles detect radiation resistance in cancer cells via transporter proteins, enabling targeted therapy.

Elevated capillary temperature prevents hydrogen bond reformation in complementary strand nucleic acids, ensuring accurate purity quantification.

Padlock probes enable rolling circle amplification to convert short salivary miRNAs into detectable ssDNA, resolving sensitivity limits in mTBI diagnosis.

Targeted nucleic acid sequences identify CFTR mutations in African populations, resolving diagnostic bias from European-centric testing.

Identify IPF inhibitors by inducing unjammed-to-jammed transitions in fibrotic bronchial epithelial cells, resolving model accuracy limits.

ADIPOQ gene expression analysis stratifies type 2 diabetes patients, resolving the trade-off between diagnostic precision and assessment simplicity.

Protease inhibitors stabilize red blood cell proteins to resolve the trade-off between processing complexity and measurement precision in blood profiling.

Suspended pillar plates tilt during immersion to let air bubbles escape, resolving the contradiction between high throughput and reliable assay contact.

Spatially organizing probes via DNA origami resolves the trade-off between high measurement precision and low device complexity in sequencing.

A liquid biopsy assay captures cell debris markers to isolate and quantify target proteins from blood samples.

Plasma etching creates flexible nanocone arrays on Teflon AF films for broadband anti-reflective and hydrophobic surfaces.

Opposing electrodes on a capillary enable simultaneous wetting, eliminating precise alignment requirements and reducing manufacturing complexity.

Artificial exogenous reference molecules normalize sequencing data across different species, resolving batch consistency issues in large-scale detection.

Block coding reduces hybridization rounds by assigning unique barcodes to genomic segments, resolving chromosome structures within the diffraction limit.

A protein biomarker panel assesses colorectal cancer status through blood samples.

COL4A1 methylation detection reagent analyzes promoter region signals via specific capture sequences, resolving low fecal specimen sensitivity.

CCR5 antagonists inhibit metastasis by blocking chemokine receptor signaling, addressing therapy resistance in advanced disease.

A digital PCR apparatus removes air bubbles from sample containers to enable accurate fluorescence intensity measurements.

Detecting SAMD12 intronic TTTCA repeat expansions enables precise hyperexcitability diagnosis.

RNA probes detect specific gene signatures to resolve false-negative rates in lymph node metastasis diagnosis.

A prediction system classifies gastric cancer patients using mRNA expression levels of specific marker genes to determine prognosis and chemotherapy responsiveness.

Multi-locus primer pairs amplify repetitive genomic fragments to measure amplification efficiency and fragment size distribution in real-time PCR reactions.

A substrate immobilizes target nucleic acids while amplification products migrate away for detection.

Targeted mutations at positions 640 and 705 resolve the contradiction between methylated dNTP stability and low incorporation efficiency.

BUBR1 biomarker levels predict response to furazanobenzimidazoles, overcoming resistance from tubulin mutations and P-glycoprotein overexpression.